wxk001

Walter K. Kraft, MD

Contact Dr. Kraft

132 South Tenth Street
1170 Main Building
Philadelphia, PA 19107

(215) 955-9077
(215) 955-5681 fax

Most Recent Peer-reviewed Publications

  1. Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling
  2. The Pharmacokinetics and Pharmacodynamics of Buprenorphine in Neonatal Abstinence Syndrome
  3. Buprenorphine in Neonatal Abstinence Syndrome
  4. Drug-Drug Interaction Study of Apixaban with Cyclosporine and Tacrolimus in Healthy Volunteers
  5. The Impact of a Transition of Care Program on Acute Myocardial Infarction Readmission Rates
  6. Medication Complications in Extracorporeal Membrane Oxygenation
  7. The authors reply
  8. The Nephrotoxicity of Vancomycin
  9. Tumor necrosis factor inhibitors in psoriatic arthritis
  10. Buprenorphine for the treatment of the neonatal abstinence syndrome
  11. Bioactivity of oral linaclotide in human colorectum for cancer chemoprevention
  12. A population pharmacokinetic model for vancomycin in adult patients receiving extracorporeal membrane oxygenation therapy
  13. Beta-blocker therapy and impact on outcome after aneurysmal subarachnoid hemorrhage: A cohort study
  14. Effect of Vorapaxar Alone and in Combination with Aspirin on Bleeding Time and Platelet Aggregation in Healthy Adult Subjects
  15. Reversibility of Apixaban Anticoagulation with a Four-Factor Prothrombin Complex Concentrate in Healthy Volunteers
  16. Neonatal abstinence syndrome: Pharmacologic strategies for the mother and infant
  17. A Two-Step Haploidentical Versus a Two-Step Matched Related Allogeneic Myeloablative Peripheral Blood Stem Cell Transplantation
  18. Population Pharmacokinetic Model of Sublingual Buprenorphine in Neonatal Abstinence Syndrome
  19. Pharmacologic and clinical evaluation of posaconazole
  20. Ethanol Pharmacokinetics in Neonates and Infants